Vivo Capital VIII, LLC, Ten Percent Owner at Timber Pharmaceuticals, holds 2.31M shares in Impel Pharmaceuticals (Ticker: IMPL), holds 3.78M shares in Bolt Biotherapeutics (Ticker: BOLT), holds 2.68M shares in Terns Pharmaceuticals (Ticker: TERN). Most recently, Vivo Capital VIII, LLC Sold ― shares of Impel Pharmaceuticals on Dec 19, 2023 for an estimated value of 74.13K.
What is the percentage of profitable transactions made by Vivo Capital VIII, LLC?
The percentage of profitable transactions made by Vivo Capital VIII, LLC is 43%.
What is the average return per transaction made by Vivo Capital VIII, LLC?
The average return per transaction made by Vivo Capital VIII, LLC is -13.70%.
What stocks does Vivo Capital VIII, LLC hold?
Vivo Capital VIII, LLC holds: TMBRQ, NBRVF, VYNE, CRNX, ALGS, BOLT, TERN, IMPL stocks.
What was Vivo Capital VIII, LLC’s latest transaction?
Vivo Capital VIII, LLC latest transaction was an Informative Sell of $74.13K.
What was Vivo Capital VIII, LLC's most profitable transaction?
Vivo Capital VIII, LLC’s most profitable transaction was an Informative Sell of TMBRQ stock on March 9, 2018. The return on the trade was 70.60%.
What is Vivo Capital VIII, LLC's role in Timber Pharmaceuticals?
Vivo Capital VIII, LLC's role in Timber Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.